RWD Life Science deepens neuroscience ties at FENS Forum 2026

RWD Life Science used FENS Forum 2026 in Barcelona to showcase neuroscience research tools, meet with more than 1,000 researchers and professionals, and host a China-Europe exchange dinner. The company said the event strengthened its global partnerships as neuroscience teams look for more integrated workflows and collaboration.

Why it matters: - RWD Life Science is positioning its tools as part of the full neuroscience research workflow, not just standalone instruments. - The company’s presence at FENS Forum 2026 put it in front of a large international audience of researchers, clinicians and industry professionals. - The event gave RWD direct feedback on research needs across regions, which can shape future product development and partnerships.

What happened: - FENS Forum 2026 took place in Barcelona from July 6-10. - The forum drew more than 8,000 participants, more than 5,000 scientific abstracts and more than 300 speakers. - RWD Life Science connected with more than 1,000 researchers and professionals during the event. - RWD exhibited at Booth #132 and held product demonstrations, scientific discussions and networking sessions. - RWD also hosted the China-Europe Neuroscience Exchange Dinner during the conference.

The details: - RWD showcased neuroscience research solutions covering animal models, behavioral studies, neural recording, imaging and tissue analysis. - The company highlighted fiber photometry systems, an intelligent optogenetics system, an in vivo imaging system and inhalation anesthesia systems. - Live demonstrations and technical discussions focused on improving experimental efficiency, data acquisition and reliability across neuroscience applications. - RWD emphasized workflow-oriented solutions that integrate technologies across multiple stages of experimentation. - The company said its goal is to help scientists accelerate discoveries and advance understanding of the brain. - RWD Life Science was established in 2002 and is headquartered in Shenzhen, China. - The company says its products and services are available in more than 100 countries and regions. - RWD says it supports more than 1,000 research institutes, 2,500 hospitals, 6,000 universities, 15,000 veterinary clinics and 2,000 biopharmaceutical companies worldwide. - RWD-enabled innovations have contributed to more than 14,500 SCI-indexed publications. - The company’s website is RWD Life Science.

Between the lines: - RWD is trying to move beyond product visibility and into relationship-building with the neuroscience community. - The China-Europe dinner suggests the company sees international collaboration as part of its market strategy, not just a side event. - The forum’s scale gave RWD a chance to frame its portfolio around broader research needs rather than a single device category. - Several attendees described the dinner as “insightful” and said “science builds bridges” across borders.

What’s next: - RWD said it will continue working with researchers, universities and industry partners to develop technologies for neuroscience discovery. - The company plans to keep focusing on innovation, accessibility and collaboration as neuroscience research evolves. - RWD expects to use insights from FENS Forum 2026 to refine future solutions and strengthen global partnerships.

The bottom line: - RWD Life Science left FENS Forum 2026 with more visibility, more contacts and a clearer read on where neuroscience research tools are headed.